Stock Events

Stock Events

Processa Pharmaceuticals (PCSA) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-1.03

-0.79

-0.54

-0.3

Details

Expected EPS

-0.49

Actual EPS

-0.3

Surprise EPS

0.19

Surprise Percent

+38.78%

Description

Processa Pharmaceuticals (PCSA) has reported earnings of -0.3 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.